Abstract:Objective: Limited data are available on the effects of nifedipine gastrointestinal therapeutic system (GITS) on arterial stiffness in hypertensive Chinese patients. This study evaluated the efficacy of nifedipine GITS on arterial stiffness and structural vascular lesions in mild hypertensive Chinese patients with increased pulse wave velocity (PWV). Design and method: This single-center, single-group, open-label, prospective, phase IV study recruited patients with mild hypertension and increased PWV from December 2013 to December 2014 (N = 138; age, 18–75 years; systolic blood pressure (SBP),>140 mmHg,<160 mmHg; diastolic BP (DBP),>90 mmHg,<100 mmHg; increased brachial-ankle PWV [baPWV,12 ms1]). Nifedipine GITS (30 mg/d) was administered for 24 weeks to achieve target BP of <140/90 mmHg. The dose was up-titrated of 60 mg/d in case of unsatisfactory BP reduction after 4 weeks. Primary study end point was the change in baPWV after nifedipine GITS treatment. Hemodynamic parameters (office BP, 24-h ambulatory BP monitoring (ABPM), heart rate (HR) and baPWV) were evaluated at baseline and followed-up at 2, 4, 8, 12, 18 and 24 weeks. Results: A majority of the patients (n = 117; 84.8%) completed the study. baPWV decreased significantly at 4 weeks compared with baseline (1598.87 ± 239.82 cm/s vs. 1500.89 ± 241.15 cm/s,P < .001) and remained stable at 12 weeks (1482.24 ± 215.14 cm/s,P < .001) and maintained steadily up to 24 weeks (1472.58 ± 205.01 cm/s,P < .001). Office BP reduced from baseline to week 4 (154/95 mmHg vs 136/85 mmHg) and maintained until 24 weeks. Nifedipine GITS significantly decreased 24-h ABPM (P < .001) after 24 weeks from baseline. Mean arterial pressure (MAP) and pulse pressure were lowered significantly after 4, 12 and 24 weeks treatment (P < .001). HR did not change significantly at any time point compared with baseline (P > .05). Multiple linear regression analysis revealed that baPWV were significantly correlated with changes in SBP, DBP, and MAP (P < .05), but not with changes in pulse pressure (P > .05). Conclusions: baPWV was significantly decreased after the administration of nifedipine GITS in patients with mild hypertension and increased PWV. Improvement in arterial stiffness was seen after 4 weeks, reflecting the BP-lowering effects of nifedipine GITS.

Effect Of Nifedipine Controlled Released Tablets (Xinran) On Home Morning Blood Pressure In Mild-To-Moderate Hypertension: A Multicenter, Randomized, Active-Controlled Clinical Trial In China

A18207 Effect of Nifedipine Controlled Released Tablets (xinran) on Home Morning Blood Pressure in Mild-to-moderate Hypertension

Blood Pressure Lowering Efficacy Of Amlodipine And Nifedipine-Gits In Ambulatory Hypertension

Multicenter Clinical Trial on Benidipine in the Treatment of Stable Angina Pectoris

A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension.

[PP.02.03] EFFICACY AND TOLERABILITY OF NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYTEM 60MG IN CHINESE PATIENTS WITH UNCONTROLLED HYPERTENSION

Double-Blind, Multicenter, Active-Controlled, Randomized Clinical Trial to Assess the Safety and Efficacy of Orally Administered Nicorandil in Patients with Stable Angina Pectoris in China

Efficacy And Safety Of Nifedipine Gits In Asians With Hypertension - Results Of A Post-Marketing Surveillance Study In China

BLOOD PRESSURE CONTROL OF NIFEDIPINE GITS 60MG TREATMENT IN PREVIOUSLY UNCONTROLLED HYPERTENSIVE PATIENTS: A PROSPECTIVE, OPEN-LABEL, MULTICENTER, SINGLE-ARM, 8WEEK STUDY

BLOOD PRESSURE CONTROL OF NIFEDIPINE GITS 60MG TREATMENT IN PREVIOUSLY UNCONTROLLED HYPERTENSIVE PATIENTS

A Randomized Multicenter Study on Ambulatory Blood Pressure and Arterial Stiffness in Patients Treated with Valsartan/amlodipine or Nifedipine GITS.

Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL)

[PP.26.12] EFFICACY OF NIFEDIPINE GASTROINTESTINAL SYSTEM ON ARTERIAL STIFFNESS AND STRUCTURAL VASCULAR LESIONS IN MILD HYPERTENSIVE CHINESE PATIENTS WITH INCREASED PULSE WAVE VELOCITY

Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension

Effects of the Valsartan/amlodipine Combination and Nifedipine Gastrointestinal Therapeutic System Monotherapy on Brachial Pulse Pressure and Radial Augmentation Index in Hypertensive Patients

EFFICACY AND SAFETY OF NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM VERSUS RAMIPRIL IN CHINESE AND EUROPEAN PATIENTS WITH HYPERTENSION.

Efficacy and safety of nifedipine GITS in Chinese patients with hypertension--a post-marketing surveillance study.

Nifedipine sustained-release tablets and amlodipine besylate tablets in treatment of hypertension

PS-C12-8: BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS RANDOMIZED TO NIFEDIPINE GITS OR RAMIPRIL. REVERENT STUDY

Effect of nifedipine controlled released tablet and atorvastatin on carotid intimamedia thickness and vascular endothelial function in patients with hypertension

Current Status of Morning Blood Pressure Control and Medication of Hypertensive Patients in Beijing